-
Sector Analysis
Non-Small Cell Lung Cancer (NSCLC) Epidemiology Analysis and Forecast to 2032
Non-Small Cell Lung Cancer (NSCLC) Report Overview In the 8MM, there were 1,097,467 diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) in 2022. The diagnosed incident cases of Non-Small Cell Lung Cancer (NSCLC) will register an AGR of more than 2% during 2022-2032. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, NSCLC can begin anywhere in the lungs when the healthy cells that make up the lining of the lungs change and grow out...
-
Analyst Opinions
Online Travel Market Trends and Analysis by Advertising Activity, Challenges, Opportunities and Case Studies, 2023 Update
Online Travel Market Trends Analysis Report Overview The online travel market size in 2022 was estimated at $660.95 billion. The growth is attributed to the effective COVID-19 vaccination programs that contributed to the easing of travel restrictions. Moreover, COVID-19 accelerated the need for travel and tourism companies to adopt a digital strategy as the global pandemic highlighted the need to reduce physical contact, and consumers are still more likely than before to carry out transactions online. Travelers’ requirements are constantly...
-
Sector Analysis
Syringes, Needles, and Urinary Catheters Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Syringes, Needles, and Urinary Catheters Market Report Overview The syringes, needles, and urinary catheters market size was $25.28 billion in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. The market for syringes, needles, and urinary catheters is profoundly intertwined with healthcare delivery and patient management. These medical devices serve various purposes, from administering medications and vaccines to facilitating urine drainage in individuals with specific medical conditions. Syringes, Needles, and Urinary Catheters Market...
-
Thematic Analysis
Impact of Inflation on the Healthcare Sector, H2 2023 – Thematic Intelligence
Impact of Inflation on the Healthcare Sector Overview The wide availability of COVID-19 vaccines allowed economies and societies to safely reopen. However, factors such as supply-demand imbalance, inflation, recession prospects, market volatility, and geopolitical tensions and conflicts are hampering the economic recovery and growth prospects. These factors will have a reciprocal impact on healthcare services as well in 2024. The Impact of Inflation on the Healthcare Sector, H2 2023 report assesses inflation's impact on the treatment of patients and identifies...
-
Track & Monitor
Covid-19 in pharma: synthetic COVID vaccines
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s synthetic COVID vaccines segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tocilizumab Biosimilar in Polyarticular Juvenile Idiopathic Arthritis (PJIA)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tocilizumab Biosimilar in Polyarticular Juvenile Idiopathic Arthritis (PJIA) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tocilizumab Biosimilar in Polyarticular Juvenile Idiopathic Arthritis (PJIA)...
-
Product Insights
Transdermal Drug Delivery Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transdermal Drug Delivery Pipeline Market Report Overview Transdermal drug delivery devices are medicated adhesive patches placed on the skin to deliver a specific dose of medication through the skin into the bloodstream. The Transdermal Drug Delivery pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tertomotide in Progressive Supranuclear Palsy
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Tertomotide in Progressive Supranuclear Palsy Drug Details: Tertomotide hydrochloride (Riavax) is a peptide vaccine. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Covid/Influenza Combination Vaccine in Seasonal Influenza
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Covid/Influenza Combination Vaccine in Seasonal Influenza Drug Details:ICC vaccine is under development for the prevention of seasonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – InCVAX in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. InCVAX in Non-Small Cell Lung Cancer Drug Details: inCVAX is under development for the treatment...